To compare the clinical characteristics and the long-term outcome of a large series of patients with blepharospasm (BS) treated with the two most used brands of BoNT-A over the last 15 years.
Bentivoglio, A. R., Fasano, A., Ialongo, T., Soleti, F., Lo Fermo, S., Albanese, A., Fifteen-year experience in treating blepharospasm with Botox or Dysport: same toxin, two drugs, <<NEUROTOXICITY RESEARCH>>, 2009; 15 (3): 224-231. [doi:10.1007/s12640-009-9023-3] [http://hdl.handle.net/10807/28008]
Fifteen-year experience in treating blepharospasm with Botox or Dysport: same toxin, two drugs
Bentivoglio, Anna Rita;Fasano, Alfonso;Ialongo, Tamara;Soleti, Francesco;Albanese, Alberto
2009
Abstract
To compare the clinical characteristics and the long-term outcome of a large series of patients with blepharospasm (BS) treated with the two most used brands of BoNT-A over the last 15 years.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.